Is Kymera International public?
Is Kymera International a private or public company? Kymera International is a Private company. The current market capitalization of Kymera Therapeutics is $3. B.Kymera Therapeutics has 208 employees What industry does Kymera Therapeutics belong to?
Is Kymera public?
Kymera Therapeutics has successfully priced a public offering of $250. The offering includes both common stock and pre-funded warrants, indicating strong investor interest and flexibility in financing options. The gross proceeds to Kymera from the offering are expected to be approximately $250. Kymera, excluding the exercise of any pre-funded warrants and assuming no exercise of the underwriters’ option to purchase .
How many employees does Kymera Therapeutics have?
Kymera Therapeutics has 208 total employees. About Kymera Therapeutics Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www. X or LinkedIn.Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.Kymera Therapeutics’s competitors and similar companies include Foghorn Therapeutics, XBiotech, Adicet Bio and Jnana.